Tivic Health targets FDA approval for Entolimod within 18 months, highlights transformation into biopharma
Q4 2024 Management View CEO Jennifer Ernst highlighted significant advancements, including the acquisition of exclusive worldwide rights to the Phase III immunomodulatory drug candidate Entolimod, ...
Labiotech.eu13h
Depression drug trials are failing—and placebos are to blame
Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...
Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Moore: FDA can save lives by nixing copycat drugs
The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...
ABP News21h
Mounjaro Enters India: The Weight Loss & Diabetes Drug May Have These Side Effects; Know Price
Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.